StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific lợi nhuận hoạt động phân khúc (Segment Income) — Laboratory Products & Biopharma Services ($M)

Bóc tách đầy đủ doanh thu ngoại vi/nội bộ, Giá vốn, SG&A, R&D, Tài sản vận hành (AR + Inventory), CapEx và Khấu hao theo chuẩn kế toán mới ASU 2023-07.

QuarterlyAnnual
Latest, Q3 2026
1,067
Period ended Sep 30, 2026
Change on a year earlier
+22.9%
868 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLợi nhuận hoạt động phân khúc (Segment Income) — Laboratory Products & Biopharma Services ($M)Year on yearSource
Q3 2026Sep 30, 20261,067+22.9%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 2026936+13.5%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 2026778+6.4%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 2025925+11.7%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 2025868+12.3%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 2025825+10.7%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 2025731-1.7%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 2024828+3.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 2024773-17.5%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 2024745-9.6%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024744-6.2%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 2023804-3.8%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 2023937+29.2%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 2023824+19.2%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 2023793+27.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 2022836–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up lợi nhuận hoạt động phân khúc (segment income) — laboratory products & biopharma services

Cite this data

StockData. (2026). Thermo Fisher Scientific Lợi nhuận hoạt động phân khúc (Segment Income) — Laboratory Products & Biopharma Services ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_income_lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.